Literature DB >> 10137673

Pilot testing of the Canadian Occupational Performance Measure: clinical and measurement issues.

M Law1, H Polatajko, N Pollock, M A McColl, A Carswell, S Baptiste.   

Abstract

The Canadian Occupational Performance Measure (COPM) is a measure of a client's self-perception of occupational performance in the areas of self-care, productivity and leisure. The COPM is administered using a semi-structured interview in which the client identifies significant issues in daily activities which are causing difficulty. Extensive pilot testing of the COPM has been completed with 268 clients in communities across Canada and in New Zealand, Greece and Britain. Results indicate the COPM has a median administration time of 30 minutes, is able to identify a wide range of occupational performance issues and appears to be responsive to changes in measurement issues centering around the interview, test construction, scoring, timing of the assessment, respondents, and the assessment process are discussed.

Mesh:

Year:  1994        PMID: 10137673     DOI: 10.1177/000841749406100403

Source DB:  PubMed          Journal:  Can J Occup Ther        ISSN: 0008-4174            Impact factor:   1.614


  28 in total

1.  Client-centred assessment and the identification of meaningful treatment goals for individuals with a spinal cord injury.

Authors:  C Donnelly; J J Eng; J Hall; L Alford; R Giachino; K Norton; D S Kerr
Journal:  Spinal Cord       Date:  2004-05       Impact factor: 2.772

2.  The impact of task-oriented client-centered training on individuals with spinal cord injury in the community.

Authors:  A Chompoonimit; N Nualnetr
Journal:  Spinal Cord       Date:  2016-01-12       Impact factor: 2.772

3.  Determinants of quality of life in children with chronic somatic disease: pilot data from the GapS Questionnaire.

Authors:  Bryn D Webb; Maru Barrera; Joseph Beyene; Manuel Carcao; Denis Daneman; Irene Elliott; Grace W K Gong; Ilana J Halperin; Sarah Lord; Heather Melville; Unni G Narayanan; Sylvia Ota; Melinda Solomon; Lillian Sung; Nancy L Young; Mary Zachos; Brian M Feldman
Journal:  Qual Life Res       Date:  2012-03-30       Impact factor: 4.147

4.  Development and pre-testing of a rehabilitation planning consultation for head-and-neck cancer.

Authors:  S McEwen; C Dunphy; J Norman Rios; A Davis; J Jones; A Lam; I Poon; R Martino; J Ringash
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

5.  Effectiveness of a Tailored Intervention for Women With Attention Deficit Hyperactivity Disorder (ADHD) and ADHD Symptoms: A Randomized Controlled Study.

Authors:  Sharon A Gutman; Sheetala Balasubramanian; Maya Herzog; Elizabeth Kim; Hannah Swirnow; Yudis Retig; Samantha Wolff
Journal:  Am J Occup Ther       Date:  2020 Jan/Feb

6.  Goal Priorities Identified through Client-Centred Measurement in Individuals with Chronic Stroke.

Authors:  Jocelyn E Harris; Janice J Eng
Journal:  Physiother Can       Date:  2004-06       Impact factor: 1.037

7.  The applications of PROs in clinical practice: what are they, do they work, and why?

Authors:  Joanne Greenhalgh
Journal:  Qual Life Res       Date:  2008-12-23       Impact factor: 4.147

8.  Interdisciplinary residential treatment of posttraumatic stress disorder and traumatic brain injury: effects on symptom severity and occupational performance and satisfaction.

Authors:  Sarah M Speicher; Kristen H Walter; Kathleen M Chard
Journal:  Am J Occup Ther       Date:  2014 Jul-Aug

9.  A community-based group exercise program for persons with chronic stroke.

Authors:  Janice J Eng; Kelly S Chu; C Maria Kim; Andrew S Dawson; Anne Carswell; Katherine E Hepburn
Journal:  Med Sci Sports Exerc       Date:  2003-08       Impact factor: 5.411

10.  INCITE: A randomised trial comparing constraint induced movement therapy and bimanual training in children with congenital hemiplegia.

Authors:  Roslyn Boyd; Leanne Sakzewski; Jenny Ziviani; David F Abbott; Radwa Badawy; Rose Gilmore; Kerry Provan; Jacques-Donald Tournier; Richard A L Macdonell; Graeme D Jackson
Journal:  BMC Neurol       Date:  2010-01-12       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.